Global Codeine Market Professional Survey Report 2016
- QYR608226
- 107 Pages
- June 2016
- Pharmaceuticals
Product types including
Extracted from Opium
Synthesized by Morphine
The segment applications including
Narcotic Analgesic
Antitussive
Segment regions including (the separated region report can also be offered)
EU
USA
India
Japan
China
The players list (Partly, Players you are interested in can also be added)
Macfarian Smith
Francopia
Noramco
Weifa
Mallinckrodt
Temad
GSK
Alkaloida
Tas. Alkaloids
Alcaliber
Fine Chemicals
Aesica
SINO PHARM
Sri Krishna
TPI
With 15 top producers.
Data including (both global and regions): Market Size (both volume - Kg and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/g, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Codeine
1.1 Definition and Specifications of Codeine
1.1.1 Definition of Codeine
1.1.2 Specifications of Codeine
1.2 Classification of Codeine
1.2.1 Extracted from Opium
1.2.2 Synthesized by Morphine
1.3 Applications of Codeine
1.3.1 Narcotic Analgesic
1.3.2 Antitussive
1.4 Industry Chain Structure of Codeine
1.5 Industry Overview and Major Regions Status of Codeine
1.5.1 Industry Overview of Codeine
1.5.2 Global Major Regions Status of Codeine
1.6 Industry Policy Analysis of Codeine
1.7 Industry News Analysis of Codeine
2 Manufacturing Cost Structure Analysis of Codeine
2.1 Raw Material Suppliers and Price Analysis of Codeine
2.2 Equipment Suppliers and Price Analysis of Codeine
2.3 Labor Cost Analysis of Codeine
2.4 Other Costs Analysis of Codeine
2.5 Manufacturing Cost Structure Analysis of Codeine
2.6 Manufacturing Process Analysis of Codeine
3 Technical Data and Manufacturing Plants Analysis of Codeine
3.1 Capacity and Commercial Production Date of Global Codeine Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Codeine Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Codeine Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Codeine Major Manufacturers in 2015
4 Global Codeine Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Codeine Capacity and Growth Rate Analysis
4.2.2 2015 Codeine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Codeine Sales and Growth Rate Analysis
4.3.2 2015 Codeine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Codeine Sales Price
4.4.2 2015 Codeine Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Codeine Gross Margin
4.5.2 2015 Codeine Gross Margin Analysis (Company Segment)
5 Codeine Regional Market Analysis
5.1 EU Codeine Market Analysis
5.1.1 EU Codeine Market Overview
5.1.2 EU 2011-2016E Codeine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 EU 2011-2016E Codeine Sales Price Analysis
5.1.4 EU 2015 Codeine Market Share Analysis
5.2 USA Codeine Market Analysis
5.2.1 USA Codeine Market Overview
5.2.2 USA 2011-2016E Codeine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 USA 2011-2016E Codeine Sales Price Analysis
5.2.4 USA 2015 Codeine Market Share Analysis
5.3 India Codeine Market Analysis
5.3.1 India Codeine Market Overview
5.3.2 India 2011-2016E Codeine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 India 2011-2016E Codeine Sales Price Analysis
5.3.4 India 2015 Codeine Market Share Analysis
5.4 Japan Codeine Market Analysis
5.4.1 Japan Codeine Market Overview
5.4.2 Japan 2011-2016E Codeine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2011-2016E Codeine Sales Price Analysis
5.4.4 Japan 2015 Codeine Market Share Analysis
5.5 China Codeine Market Analysis
5.5.1 China Codeine Market Overview
5.5.2 China 2011-2016E Codeine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 China 2011-2016E Codeine Sales Price Analysis
5.5.4 China 2015 Codeine Market Share Analysis
6 Global 2011-2016E Codeine Segment Market Analysis (by Type)
6.1 Global 2011-2016E Codeine Sales by Type
6.2 Different Types Codeine Product Interview Price Analysis
6.3 Different Types Codeine Product Driving Factors Analysis
6.3.1 Extracted from Opium Codeine Growth Driving Factor Analysis
6.3.2 Synthesized by Morphine Codeine Growth Driving Factor Analysis
7 Global 2011-2016E Codeine Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Narcotic Analgesic Codeine Growth Driving Factor Analysis
7.3.2 Antitussive Codeine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Codeine
8.1 Macfarian Smith
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Macfarian Smith 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Macfarian Smith 2015 Codeine Business Region Distribution Analysis
8.2 Francopia
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Francopia 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Francopia 2015 Codeine Business Region Distribution Analysis
8.3 Noramco
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Noramco 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Noramco 2015 Codeine Business Region Distribution Analysis
8.4 Weifa
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Weifa 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Weifa 2015 Codeine Business Region Distribution Analysis
8.5 Mallinckrodt
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Mallinckrodt 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mallinckrodt 2015 Codeine Business Region Distribution Analysis
8.6 Temad
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Temad 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Temad 2015 Codeine Business Region Distribution Analysis
8.7 GSK
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 GSK 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 GSK 2015 Codeine Business Region Distribution Analysis
8.8 Alkaloida
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Alkaloida 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Alkaloida 2015 Codeine Business Region Distribution Analysis
8.9 Tas. Alkaloids
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Tas. Alkaloids 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Tas. Alkaloids 2015 Codeine Business Region Distribution Analysis
8.10 Alcaliber
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Alcaliber 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Alcaliber 2015 Codeine Business Region Distribution Analysis
8.11 Fine Chemicals
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Fine Chemicals 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Fine Chemicals 2015 Codeine Business Region Distribution Analysis
8.12 Aesica
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Aesica 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Aesica 2015 Codeine Business Region Distribution Analysis
8.13 SINO PHARM
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 SINO PHARM 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 SINO PHARM 2015 Codeine Business Region Distribution Analysis
8.14 Sri Krishna
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Sri Krishna 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Sri Krishna 2015 Codeine Business Region Distribution Analysis
8.15 TPI
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 TPI 2015 Codeine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 TPI 2015 Codeine Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 EU 2016-2021 Codeine Consumption Forecast
9.2.2 USA 2016-2021 Codeine Consumption Forecast
9.2.3 India 2016-2021 Codeine Consumption Forecast
9.2.4 Japan 2016-2021 Codeine Consumption Forecast
9.2.5 China 2016-2021 Codeine Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Codeine Marketing Model Analysis
10.1 Codeine Regional Marketing Model Analysis
10.2 Codeine International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Codeine by Regions
10.4 Codeine Supply Chain Analysis
11 Consumers Analysis of Codeine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Codeine
12.1 New Project SWOT Analysis of Codeine
12.2 New Project Investment Feasibility Analysis of Codeine
13 Conclusion of the Global Codeine Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
